These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15963835)

  • 1. The molecular physiology and pathology of fibrin structure/function.
    Standeven KF; Ariëns RA; Grant PJ
    Blood Rev; 2005 Sep; 19(5):275-88. PubMed ID: 15963835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen and fibrin: scaffold proteins in hemostasis.
    Lord ST
    Curr Opin Hematol; 2007 May; 14(3):236-41. PubMed ID: 17414213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.
    Scott EM; Ariëns RA; Grant PJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1558-66. PubMed ID: 15217804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
    Standeven KF; Grant PJ; Carter AM; Scheiner T; Weisel JW; Ariëns RA
    Circulation; 2003 May; 107(18):2326-30. PubMed ID: 12707238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heritability of clot formation.
    Standeven KF; Uitte de Willige S; Carter AM; Grant PJ
    Semin Thromb Hemost; 2009 Jul; 35(5):458-67. PubMed ID: 19739036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen structure and fibrin clot assembly.
    Mosesson MW
    Semin Thromb Hemost; 1998; 24(2):169-74. PubMed ID: 9579639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
    Kobbervig C; Williams E
    Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of clotting factors and fibrin structure in predisposition to atherothrombotic disease.
    Ajjan RA; Grant PJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1047-59. PubMed ID: 16292996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin clot formation and lysis: basic mechanisms.
    Sidelmann JJ; Gram J; Jespersen J; Kluft C
    Semin Thromb Hemost; 2000; 26(6):605-18. PubMed ID: 11140797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of fibrin clot elasticity.
    Lim BB; Lee EH; Sotomayor M; Schulten K
    Structure; 2008 Mar; 16(3):449-59. PubMed ID: 18294856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elastic modulus of fibrin clots and fibrinogen gels: the effect of fibronectin and dithiothreitol.
    Procyk R; King RG
    Biopolymers; 1990 Feb; 29(3):559-65. PubMed ID: 1970486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.
    Alzahrani SH; Hess K; Price JF; Strachan M; Baxter PD; Cubbon R; Phoenix F; Gamlen T; Ariëns RA; Grant PJ; Ajjan RA
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2282-7. PubMed ID: 22996148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheology of blood coagulation.
    Kaibara M
    Biorheology; 1996; 33(2):101-17. PubMed ID: 8679959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of alpha-polymers and residual alpha-chains in in vitro and in vivo formed fibrin clots.
    Barthels M; Förstermann U; Sosada M; Poliwoda H
    Behring Inst Mitt; 1986 Feb; (79):24-30. PubMed ID: 3718409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
    Undas A; Kolarz M; Kopeć G; Tracz W
    Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinogen, a vascular risk factor].
    Caen JP; Soria J; Collet JP; Soria C
    Bull Acad Natl Med; 1993 Nov; 177(8):1433-41; discussion 1441-4. PubMed ID: 8193948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spatial aspects of blood coagulation dynamics. III. Growth of clots in vitro].
    Ataullakhanov FI; Volkova RI; Guriia GT; Sarbash VI
    Biofizika; 1995; 40(6):1320-8. PubMed ID: 8590724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F; Kani S; Hongo M; Okumura N
    Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of fibrinogen α
    Martinez-Torres C; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2024 Mar; 22(3):715-726. PubMed ID: 37940047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.